Prostate Specific Antigen Rapid Test Device (WB/S/P)

PSA rapid testing is used to detect Prostate Specific Antigen in whole blood, serum, or plasma samples. PSA is a protein produced by the prostate gland. Higher PSA levels may be linked with prostate enlargement, prostatitis, infection, or prostate cancer risk, so medical interpretation is important.

• The Prostate Specific Antigen Rapid Test helps support early prostate health screening.
• Many men with early prostate conditions may not have clear symptoms, so PSA testing can help guide further medical evaluation.
• The PSA Rapid Test Device may support elevated PSA screening, urology consultation, preventive health checkups, and men’s health programs.
• A raised PSA result does not confirm prostate cancer and should be reviewed with clinical history and further diagnostic testing.

The PSA Rapid Test Device by LARKSOIS Pharma may be used in professional diagnostic and prostate health screening environments.

Applications

• Prostate health assessment
• Elevated PSA screening
• Urology consultation support
• Preventive health checkups
• Men’s health screening programs
• Monitoring support after medical advice
• Laboratory and point-of-care testing
• Tumor marker screening programs
• International diagnostic distribution

• The PSA Rapid Test Device works through a lateral flow immunoassay method.
• A whole blood, serum, or plasma sample is applied to the test device.
• The sample migrates across the membrane and reacts with PSA-specific antibodies.
• If PSA is present at or above the test threshold, a visible test line appears according to the instructions for use.

The PSA Rapid Test Device uses rapid lateral flow immunochromatographic technology for qualitative or semi-quantitative detection of Prostate Specific Antigen in whole blood, serum, or plasma specimens.

Benefits

• Rapid PSA detection
• Suitable for whole blood, serum, or plasma
• Simple test procedure
• Professional diagnostic use
• Supports prostate health screening
• Useful for clinics, hospitals, and laboratories
• Practical point-of-care format
• Easy result interpretation

The PSA Rapid Test Device is designed for whole blood, serum, or plasma specimens. Correct specimen collection and handling are important for reliable test performance.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean sample collection materials
• Avoid contaminated or improperly stored samples
• Add whole blood, serum, or plasma to the sample well
• Add buffer as instructed
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, handling, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The PSA Rapid Test Device by LARKSOIS Pharma is designed to detect Prostate Specific Antigen in whole blood, serum, or plasma samples. It supports quick prostate screening workflows and helps identify patients who may need further medical evaluation.

• PSA testing may support prostate health screening and early risk assessment.
• High PSA may occur due to prostate cancer or non-cancerous prostate conditions such as infection or enlarged prostate.
• Healthcare professionals should interpret PSA results with age, symptoms, risk factors, and medical history.
• If PSA is elevated, doctors may recommend repeat PSA testing, physical examination, imaging, biopsy, or other diagnostic tests.

The PSA Rapid Test Device is a screening aid and should not be used alone to diagnose prostate cancer. Results should be interpreted with age, symptoms, clinical history, examination findings, and confirmatory laboratory testing.

Instructions

• The test does not confirm prostate cancer on its own
• High PSA may occur due to benign prostate enlargement, prostatitis, infection, recent procedures, or age-related changes
• Incorrect specimen handling may affect results
• False positive or false negative results may occur
• Results should be interpreted with clinical findings
• Additional laboratory testing may be required
• Follow the official product insert carefully
• Use only valid whole blood, serum, or plasma samples

Instructions

• Rapid PSA detection
• Suitable for whole blood, serum, or plasma
• Simple test procedure
• Professional diagnostic use
• Supports prostate health screening
• Useful for clinics, hospitals, and laboratories
• Practical point-of-care format
• Suitable for international diagnostic markets

Note

The PSA Rapid Test Device by LARKSOIS Pharma is developed for professional users who need fast and practical prostate screening support.

Steps

• Bring the test device, sample, and buffer to room temperature
• Remove the cassette from the sealed pouch
• Place it on a clean and flat surface
• Add whole blood, serum, or plasma to the sample well
• Add buffer as instructed
• Wait for the recommended reaction time
• Read test and control lines within the valid time window
• Do not read results after the recommended time
• Dispose of used materials according to laboratory safety rules

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

Positive or elevated PSA result means PSA may be above the test threshold. Further medical evaluation is recommended.

Negative

A negative result means PSA was not detected above the test cut-off level.

Invalid

If the control line does not appear, the test is invalid and should be repeated with a new device according to the product insert.

Instructions

• Store the PSA Rapid Test Device according to the label and product insert
• Store in a dry place
• Keep sealed until use
• Protect from moisture
• Avoid direct sunlight
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood samples as potentially infectious
• Wear gloves during sample handling
• Do not reuse the test cassette
• Avoid specimen cross-contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Confirm results with clinical evaluation when required

LARKSOIS Pharma provides professional diagnostic products for international healthcare markets. The PSA Rapid Test Device is designed to support quick prostate screening workflows and dependable clinical use for hospitals, laboratories, clinics, and distributors.

Advantages

• International diagnostic product portfolio
• Tumor marker rapid test range
• Suitable for global distributors
• Professional healthcare quality focus
• Practical point-of-care diagnostic format
• Reliable supply for hospitals and laboratories
• Export-ready diagnostic product positioning